trending Market Intelligence /marketintelligence/en/news-insights/trending/s-v8vasmn2_izdsx1epjiq2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Zosano prices $50M common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Zosano prices $50M common stock offering

Zosano Pharma Corp. priced an underwritten public offering of 10 million common shares at $5 apiece to raise about $50 million in gross proceeds.

The company granted the underwriters an option to buy up an additional 1.5 million shares.

Zosano intends to use the net proceeds to complete the long-term safety study of its lead product candidate M207 to treat migraines and for working capital and general corporate purposes.

The offering is expected to close April 3, subject to customary closing conditions.

BTIG LLC is acting as the book-running manager for the offering.